$11.00 2.9%
AMWL Stock Price vs. AI Score
Data gathered: January 30

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Amwell (AMWL)

Analysis generated January 14, 2025. Powered by Chat GPT.

Amwell, formally known as American Well, is a leading telehealth company that connects healthcare providers with patients through secure, digital technology solutions. This company plays a significant role in the telemedicine industry by offering a unified platform where healthcare organizations can deliver a better and efficient means of patient interaction. As the healthcare industry increasingly shifts toward digital health solutions, Amwell is uniquely positioned to benefit from this trend.

Read full AI stock Analysis

Stock Alerts - Amwell (AMWL)

company logo Amwell | January 28
Price is down by -5.3% in the last 24h.
company logo Amwell | January 23
Price is up by 5.4% in the last 24h.
company logo Amwell | January 23
Employee Rating is down by 3.5% over the last month.
company logo Amwell | January 23
Business Outlook among employees is down by 7.7% over the last month.

About Amwell

American Well Corporation, doing business as Amwell, is a telemedicine company based in Boston, Massachusetts, that connects patients with doctors over secure video.


Amwell
Price $11.00
Target Price Sign up
Volume 32,730
Market Cap $164M
Year Range $5 - $11.23
Dividend Yield 0%
Analyst Rating 14% buy
Industry Digital health

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2464M91M-28M-43M-39M-2.870
Q2 '2466M94M-28M-50M-44M-3.360
Q1 '2460M108M-48M-72M-67M-0.250
Q4 '2371M-335M406M-49M-49M-0.170
Q3 '2362M178M-116M-136M-135M-0.480

Insider Transactions View All

McNeice Paul Francis filed to sell 9,201 shares at $7.2.
January 6 '25
Paunovich Vukasin filed to sell 116,121 shares at $7.2.
January 6 '25
Gotlib Phyllis filed to sell 108,840 shares at $7.2.
January 6 '25
McNeice Paul Francis filed to sell 9,299 shares at $9.2.
December 4 '24
Gotlib Phyllis filed to sell 109,908 shares at $9.2.
December 4 '24

What is the Market Cap of Amwell?

The Market Cap of Amwell is $164M.

What is the current stock price of Amwell?

Currently, the price of one share of Amwell stock is $11.00.

How can I analyze the AMWL stock price chart for investment decisions?

The AMWL stock price chart above provides a comprehensive visual representation of Amwell's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Amwell shares. Our platform offers an up-to-date AMWL stock price chart, along with technical data analysis and alternative data insights.

Does AMWL offer dividends to its shareholders?

As of our latest update, Amwell (AMWL) does not offer dividends to its shareholders. Investors interested in Amwell should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Amwell?

Some of the similar stocks of Amwell are Teladoc Health, Veeva Systems, Doximity, GoodRx, and Lifestance Health.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.